Jianbing Huang

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity

Chengming Liu, Sufei Zheng, Runsen Jin et al. · Cancer Letters · 2019 · 280 citations · Full text

Prognostic alternative mRNA splicing signature in non-small cell lung cancer

Yuan Li, Nan Sun, Zhiliang Lu et al. · Cancer Letters · 2017 · 210 citations

Prognostic Alternative Mrna, Rna Processing, Oncology +11

Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma

Yuan Li, Zhiliang Lu, Yun Che et al. · OncoImmunology · 2017 · 132 citations · Full text

Prognostic Factors, Esophageal Cancer, Immunology +17

Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance

Yun Che, Jingnan Wang, Yuan Li et al. · Cell Death and Disease · 2018 · 128 citations · Full text

Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway

Zhiliang Lu, Yuan Li, Jingnan Wang et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 126 citations · Full text